COVID Impacts: Metabolic

Rubino F, Amiel SA, Zimmet P, et al. New-Onset Diabetes in Covid-19. N Engl J Med. 2020;383(8):789-790.

Sathish T, Anton MC, Sivakumar T. New-onset diabetes in "long COVID". J Diabetes. 2021;13(8):693-694.

Qadir MMF, Bhondeley M, Beatty W, et al. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes. JCI Insight. 2021;6(16):e151551. Published 2021 Aug 23.

Shrestha DB, Budhathoki P, Raut S, et al. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. World J Virol. 2021;10(5):275-287.

Keerthi BY, Sushmita G, Khan EA, et al. New onset diabetes mellitus in post-COVID-19 patients. J Family Med Prim Care. 2022;11(10):5961-5968.

Chourasia P, Goyal L, Kansal D, et al. Risk of New-Onset Diabetes Mellitus as a Post-COVID-19 Condition and Possible Mechanisms: A Scoping Review. J Clin Med. 2023;12(3):1159. Published 2023 Feb 1.

Wihandani DM, Purwanta MLA, Mulyani WRW, Putra IWAS, Supadmanaba IGP. New-onset diabetes in COVID-19: The molecular pathogenesis. Biomedicine (Taipei). 2023;13(1):3-12. Published 2023 Mar 1.

Kim SH, Arora I, Hsia DS, et al. New-Onset Diabetes after COVID-19 [published online ahead of print, 2023 May 19]. J Clin Endocrinol Metab. 2023;dgad284.

Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E. Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19 [published online ahead of print, 2023 May 22]. JAMA. 2023;10.1001/jama.2023.8674.

Li J, Li Y, Wang Z, Liu N, He L, Zhang H. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front Public Health. 2023;11:1170156. Published 2023 May 25.

Rahmati M, Yon DK, Lee SW, et al. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies. J Med Virol. 2023;95(6):e28833.

Sathish T, Anton MC. Persistence of new-onset diabetes in the post-acute phase of COVID-19. Int J Diabetes Dev Ctries. 2023;43(1):118-119.

Pasini E, Corsetti G, Romano C, et al. Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications. Front Med (Lausanne). 2021;8:714426. Published 2021 Jul 22.

Kazakou P, Paschou SA, Psaltopoulou T, et al. Early and late endocrine complications of COVID-19. Endocr Connect. 2021;10(9):R229-R239. Published 2021 Sep 20.

Steenblock C, Schwarz PEH, Ludwig B, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9(11):786-798.

Murugan AK, Alzahrani AS. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease. Endocrine. 2021;73(2):243-254.

López-Hernández Y, Oropeza-Valdez JJ, García Lopez DA, et al. Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery. Front Mol Biosci. 2023;10:1100486. Published 2023 Mar 3.

Steenblock C, Toepfner N, Beuschlein F, et al. SARS-CoV-2 infection and its effects on the endocrine system [published online ahead of print, 2023 Mar 5]. Best Pract Res Clin Endocrinol Metab. 2023;101761.